Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil



Document title: Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
Journal: Revista de saude publica
Database:
System number: 000535953
ISSN: 0034-8910
Authors: 1
2
1
4
5
6
3
7
8
9
Institutions: 1Hemorio, Rio de Janeiro, RJ. Brasil
2Fundação Oswaldo Cruz, Instituto de Comunicação e Informação Científica e Tecnológica em Saúde, Rio de Janeiro. Brasil
3Universidade de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo. Brasil
4Universidade do Estado do Rio de Janeiro, Instituto de Medicina Social, Rio de Janeiro, Rio de Janeiro. Brasil
5Universidade do Federal do Rio de Janeiro, Faculdade de Medicina, Rio de Janeiro, RJ. Brasil
6Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro. Brasil
7Universidade do Estado do Rio de Janeiro, Laboratório de Histocompatibilidade e Criopreservação Policlínica Piquet Carneiro, Rio de Janeiro, Rio de Janeiro. Brasil
8Secretaria de Estado do Rio de Janeiro, Rio de Janeiro, RJ. Brasil
9Universidade do Federal do Rio de Janeiro, Instituto de Estudos em Saúde Coletiva, Rio de Janeiro. Brasil
Year:
Volumen: 54
Country: Brasil
Language: Inglés
English abstract OBJECTIVE To estimate the seroprevalence of antibodies to SARS-CoV-2 among blood donors in the state of Rio de Janeiro, Brazil. METHODS Data were collected on 2,857 blood donors from April 14 to 27, 2020. This study reports crude prevalence of antibodies to SARS-CoV-2, population weighted prevalence for the state, and prevalence adjusted for test sensitivity and specificity. Logistic regression models were used to establish the correlates of SARS-CoV-2 prevalence. For the analysis, we considered collection period and site, sociodemographic characteristics, and place of residence. RESULTS The proportion of positive tests for SARS-Cov-2, without any adjustment, was 4.0% (95%CI 3.3–4.7%), and the weighted prevalence was 3.8% (95%CI 3.1–4.5%). We found lower estimates after adjusting for test sensitivity and specificity: 3.6% (95%CI 2.7–4.4%) for the non-weighted prevalence, and 3.3% (95%CI 2.6–4.1%) for the weighted prevalence. Collection period was the variable most significantly associated with crude prevalence: the later the period, the higher the prevalence. Regarding sociodemographic characteristics, the younger the blood donor, the higher the prevalence, and the lower the education level, the higher the odds of testing positive for SARS-Cov-2 antibody. We found similar results for weighted prevalence. CONCLUSIONS Our findings comply with some basic premises: the increasing trend over time, as the epidemic curve in the state is still on the rise; and the higher prevalence among both the youngest, for moving around more than older age groups, and the less educated, for encountering more difficulties in following social distancing recommendations. Despite the study limitations, we may infer that Rio de Janeiro is far from reaching the required levels of herd immunity against SARS-CoV-2.
Keyword: Coronavirus Infections, immunology,
Blood Donors,
Serologic Tests,
Seroepidemiologic Studies
Full text: Texto completo (Ver HTML) Texto completo (Ver PDF)